🔍
Search Results - sudath+hapuarachchige
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Targeted Nano-Delivery of Aurora Kinase Inhibitors for Cancer Therapy
Value Proposition· Kinase inhibition is a highly effective, targeted therapy that is standard of care for many cancers.· Aurora kinase inhibition is a promising class of these therapeutics demonstrated to successfully inhibit tumor growth and promote patient survival in various cancer indications. However, current oral administration requires...
Published: 7/24/2026
|
Inventor(s):
Sudath Hapuarachchige
Keywords(s):
Category(s):
Clinical and Disease Specializations > Oncology
,
Technology Classifications
,
Technology Classifications > Therapeutic Modalities > Repurposed Drugs
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum